ArticleEmerging microbes & infections2026
Convergent evolution of the N156K mutation in A(H1N1)pdm09 hemagglutinin contributes to antigenic drift and cluster transition.
Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The continuous antigenic evolution of influenza A(H1N1)pdm09 poses a persistent challenge to vaccine efficacy. While recent viral lineages have diverged significantly from ancestral strains, the precise molecular determinants driving the latest antigenic cluster transitions remain incompletely characterized. Here, using the broadly neutralizing monoclonal antibody 32D6 as a molecular probe, we identified a critical escape mechanism of antibody evasion in recent A(H1N1)pdm09 isolates. Through pseudovirus neutralization assays and LASSO regression analysis, we identified residue 156 in the Sa antigenic site as the key determinant of escape. Furthermore, molecular dynamics (MD) simulations and MM-GBSA calculations indicated that the N156 K mutation reduces the binding free energy at the antibody-antigen interface due to steric hindrance and electrostatic repulsion. Notably, while the N156 K mutations caused a significant reduction in pseudovirus infectivity within the earlier GD19 genetic backbone, it was fully accommodated in recent lineages. Phylogenetic analysis revealed the rapid, convergent fixation of N156 K across global isolates. These findings provide insights into the mechanism of the recent GD19-to-VI19 antigenic transition and highlight the hypothesized role of compensatory mutations in sustaining viral fitness during antigenic evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.